Diagnostic Test for Connective Tissue Disease

http://www.bizjournals.com/albuquerque/prnewswire/press_releases/New_Mexico/2015/04/28/PH92490

ALBUQUERQUE, N.M., April 28, 2015 /PRNewswire/ — Exagen Diagnostics, Inc., a commercial-stage diagnostics company committed to addressing the significant unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases, announced today that its Avise SLE+ Connective Tissue 2.0 diagnostic has achieved the milestone of 50,000 orders since launch, and that adoption continues to grow. The Avise diagnostic test assists physicians in identifying Connective Tissue Disease (CTD), including, but not limited to, Systemic Lupus Erythematosus, Sjogren’s, Systemic Sclerosis and Rheumatoid Arthritis. CTD affects over 11 million patients in the U.S. alone. The Avise test supports significantly accelerated time to diagnosis, allowing for a more appropriate course of treatment for patients…